Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX04 vs Avastin PK Study in Healthy Males
NCT03483649Phase 1Completed
- Sponsor
- Henlius
- Start
- Apr 2017
- Primary completion
- Oct 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HLX04-O in metastatic colorectal cancer (mCRC) (4 arms), sponsored by Henlius. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Last Quantifiable Concentration and Area Under the Concentration-Time Curve From Time Zero to Infinity. Started Apr 2017; status: completed.
02
Drugs
HLX04-O
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03483649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483649.